Should we screen for prostate cancer?
Abstract
Routine screening for any condition is unwarranted without evidence that the test accurately detects early disease, that early detection improves outcomes, and that benefits outweigh harms. Unfortunately, such evidence is lacking for prostate cancer. Although the test for prostate specific antigen (PSA) has reasonable sensitivity, it produces false positive results in two thirds of asymptomatic men.1 About a third of tumours detected by the test are localised and more likely to progress, but there is no good evidence that treatment improves outcomes.1 Moreover, the complications from screening and treatment may offset the potential benefits. Two recent reviews commissioned by the NHS Health Technology Assessment programme2 3 and a summary by the NHS Centre for Reviews and Dissemination4 came down against routine screening for prostate cancer and discouraged purchasers from paying for it. The reports instead encouraged further research to evaluate its effectiveness. Are these recommendations reasonable? The answer differs for populations and individuals. Deciding whether to screen a population requires an assessment of the benefits and harms to society. The average preferences of the population, rather than those of individuals, must be considered. Although some men might prefer to be screened, the interests of the …Keywords
This publication has 8 references indexed in Scilit:
- Diagnosis, management and screening of early localised prostate cancer.Health Technology Assessment, 1997
- The diagnosis, management, treatment and costs of prostate cancer in England and Wales.Health Technology Assessment, 1997
- The Impact of Informed Consent on Patient Interest in Prostate-Specific Antigen ScreeningArchives of internal medicine (1960), 1996
- The importance of patient preference in the decision to screen for prostate cancerJournal of General Internal Medicine, 1996
- Screening for Prostate Cancer with Prostate-Specific Antigen — An Examination of the EvidenceNew England Journal of Medicine, 1995
- Screening for Prostate CancerJAMA, 1994
- Changes in prostate cancer incidence and treatment in USAThe Lancet, 1994
- Barriers to Informed ConsentAnnals of Internal Medicine, 1983